Sectors
KPTI
Karyopharm Therapeutics Inc.
2.03
1 x 2.04
2 x 2.15
bid
ask
-
0.07
3.33%
1550 @ 04:00 PM
2.07 +0.04 (2.12%)
| Ytd | -72.42% | |
| 1y | -49.50% |
2.00
day range
2.15
1.91
52 week range
10.67
| Open | 2.10 | Prev Close | 2.10 | Low | 2.00 | High | 2.15 | Mkt Cap | 46.01M |
| Vol | 1.80M | Avg Vol | 1.20M | EPS | -11.61 | P/E | -0.17 | Forward P/E | -0.87 |
| Beta | 0.15 | Short Ratio | 19.48 | Inst. Own | 48.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 7.74 | 200-d Avg | 7.47 | 1yr Est | 4.50 |
| Income Statement | |||
| Total Revenue | 35.07M | ||
| Revenues (USD) | 35.07M | ||
| Cost of Revenue | 1.35M | ||
| Gross Profit | 33.72M | ||
| Operating Expenses | 60.48M | ||
| Research and Development Expense | 33.80M | ||
| Selling, General and Administrative Expense | 26.68M | ||
| Operating Income | -26.76M | ||
| Interest Expense | 12.55M | ||
| Income Tax Expense | 1000 | ||
| Net Income | -22.39M | ||
| Net Income Common Stock | -22.39M | ||
| Net Income Common Stock (USD) | -22.39M | ||
| Consolidated Income | -22.39M | ||
| Earnings per Basic Share | -1.02 | ||
| Earnings per Basic Share (USD) | -1.02 | ||
| Earnings per Diluted Share | -1.24 | ||
| Earning Before Interest & Taxes (EBIT) | -9.84M | ||
| Earning Before Interest & Taxes (USD) | -9.84M | ||
| Weighted Average Shares | 22.01M | ||
| Weighted Average Shares Diluted | 24.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 91.17M | ||
| Cash and Equivalents (USD) | 91.17M | ||
| Trade and Non-Trade Receivables | 23.36M | ||
| Current Assets | 126.33M | ||
| Property, Plant & Equipment Net | 4.50M | ||
| Total Assets | 131.42M | ||
| Debt Current | 33.25M | ||
| Total Debt | 230.87M | ||
| Current Liabilities | 117.30M | ||
| Debt Non-Current | 197.62M | ||
| Total Liabilities | 397.06M | ||
| Accumulated Retained Earnings (Deficit) | -1.78B | ||
| Accumulated Other Comprehensive Income | 43.00K | ||
| Shareholders Equity | -265.65M | ||
| Shareholders Equity (USD) | -265.65M | ||
| Assets Non-Current | 5.08M | ||
| Total Debt (USD) | 230.87M | ||
| Inventory | 3.60M | ||
| Liabilities Non-Current | 279.76M | ||
| Trade and Non-Trade Payables | 4.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.00K | ||
| Net Cash Flow from Financing | 49.80M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 30.28M | ||
| Issuance (Purchase) of Equity Shares | 49.80M | ||
| Net Cash Flow from Investing | 3.20M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 3.20M | ||
| Net Cash Flow from Operations | -22.73M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | 3.01M | ||